ESPR
Esperion Therapeutics, Inc.Healthcare$2.61
◆ Neutral
Mkt Cap: $670.3M|Float: 254.6M|SI: 13.3%|DTC: 7.0
Data as of market close Apr 2, 2026
IV Rank
26
IV Pctl
22%
HV 20d
9319.0%
52W Range
$1-$4
ATR(14)
$0.21
Exp. Move
±29.7%
P/C Ratio
0.13
Earnings
May 5
GEX Positive
DEX Long
Net Put Premium
IV Low
Max Pain Below
Exp. Move Wide
Low Put/Call
ESPR Key Options Data
- IV Rank
- 26.4%
- Total GEX
- $0.00B
- Total DEX
- $3.2M
- Max Pain
- $2.50
- Expected Move
- ±29.7%
- Put/Call OI
- 0.13
- Net Premium
- $-0.0M
- Spot Price
- $2.61
Gamma Exposure (GEX)
Delta Exposure (DEX)
Expected Move by Expiration
| Expiration | DTE | Expected Move | Move % | Lower | Upper |
|---|---|---|---|---|---|
| 2026-04-17 | 15 | ±$0.77 | ±29.7% | $1.83 | $3.38 |
| 2026-06-18 | 77 | ±$1.02 | ±39.3% | $1.58 | $3.63 |
| 2026-09-18 | 169 | ±$1.95 | ±74.7% | $0.66 | $4.56 |
| 2027-01-15 | 288 | ±$3.90 | ±149.4% | $-1.29 | $6.51 |
Explore ESPR options data including implied volatility rankings, gamma and delta exposure, max pain levels, and expected price moves. AI-generated reports provide directional, income, and earnings analysis.